DCA Systems Hemoglobin A1c Reagent Kit
Device DX - Diagnostics incl. all products and services
PDI 00630414532806
General payments
$26,062
Research payments
$2,704
Through program year 2025, $26,062 in general payments and $2,704 in research payments were reported against DCA Systems Hemoglobin A1c Reagent Kit (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,520 | 11 |
| 2024 | General | $8,309 | 20 |
| 2023 | General | $398 | 6 |
| 2022 | General | $10,835 | 12 |
| 2021 | Research | $2,704 | 1 |
Breakdown
The top 5 of 10 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
49 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.